Optimization of the Preparation of Magnetic Liposomes for the Combined Use of Magnetic Hyperthermia and Photothermia in Dual Magneto-Photothermal Cancer Therapy.
3T3 Cells
Animals
Cell Line, Tumor
Cell Survival
/ drug effects
Citric Acid
/ chemistry
Endocytosis
/ drug effects
Glioblastoma
/ drug therapy
Humans
Hyperthermia
Hyperthermia, Induced
/ instrumentation
Lasers
Liposomes
/ chemical synthesis
Magnetic Fields
Magnetite Nanoparticles
/ chemistry
Mice
Microscopy, Electron, Transmission
Nanocomposites
/ chemistry
Particle Size
Phototherapy
/ methods
liposomes
magnetic hyperthermia
magnetic nanoparticles
nanomedicine
photothermal therapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Jul 2020
22 Jul 2020
Historique:
received:
11
06
2020
revised:
15
07
2020
accepted:
20
07
2020
entrez:
26
7
2020
pubmed:
28
7
2020
medline:
5
3
2021
Statut:
epublish
Résumé
In this work, we aimed to develop liposomal nanocomposites containing citric-acid-coated iron oxide magnetic nanoparticles (CMNPs) for dual magneto-photothermal cancer therapy induced by alternating magnetic field (AMF) and near-infrared (NIR) lasers. Toward this end, CMNPs were encapsulated in cationic liposomes to form nano-sized magnetic liposomes (MLs) for simultaneous magnetic hyperthermia (MH) in the presence of AMF and photothermia (PT) induced by NIR laser exposure, which amplified the heating efficiency for dual-mode cancer cell killing and tumor therapy. Since the heating capability is directly related to the amount of entrapped CMNPs in MLs, while the liposome size is important to allow internalization by cancer cells, response surface methodology was utilized to optimize the preparation of MLs by simultaneously maximizing the encapsulation efficiency (EE) of CMNPs in MLs and minimizing the size of MLs. The experimental design was performed based on the central composite rotatable design. The accuracy of the model was verified from the validation experiments, providing a simple and effective method for fabricating the best MLs, with an EE of 87% and liposome size of 121 nm. The CMNPs and the optimized MLs were fully characterized from chemical and physical perspectives. In the presence of dual AMF and NIR laser treatment, a suspension of MLs demonstrated amplified heat generation from dual hyperthermia (MH)-photothermia (PT) in comparison with single MH or PT. In vitro cell culture experiments confirmed the efficient cellular uptake of the MLs from confocal laser scanning microscopy due to passive accumulation in human glioblastoma U87 cells originated from the cationic nature of MLs. The inducible thermal effects mediated by MLs after endocytosis also led to enhanced cytotoxicity and cumulative cell death of cancer cells in the presence of AMF-NIR lasers. This functional nanocomposite will be a potential candidate for bimodal MH-PT dual magneto-photothermal cancer therapy.
Identifiants
pubmed: 32707876
pii: ijms21155187
doi: 10.3390/ijms21155187
pmc: PMC7432522
pii:
doi:
Substances chimiques
Liposomes
0
Magnetite Nanoparticles
0
Citric Acid
2968PHW8QP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Chang Gung Memorial Hospital, Linkou
ID : CMRPD2G0081
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 106-2221-E-182-056-MY3
Références
Int J Pharm. 2007 Jun 7;337(1-2):329-35
pubmed: 17275230
Nanomaterials (Basel). 2018 Mar 27;8(4):
pubmed: 29584656
Int J Biol Macromol. 2012 Oct;51(3):299-304
pubmed: 22584079
Iran J Biotechnol. 2016 Jun;14(2):33-40
pubmed: 28959324
Int J Pharm. 2009 Apr 17;371(1-2):197-203
pubmed: 19162146
Molecules. 2018 Jun 28;23(7):
pubmed: 29958427
Acc Chem Res. 2008 Dec;41(12):1842-51
pubmed: 19053240
Int J Nanomedicine. 2011;6:3087-98
pubmed: 22163162
Front Chem. 2018 Dec 11;6:619
pubmed: 30619827
Pharm Res. 2014 Feb;31(2):401-13
pubmed: 24092051
Biomaterials. 2013 May;34(16):4078-4088
pubmed: 23465836
Biomed Opt Express. 2016 Oct 17;7(11):4581-4594
pubmed: 27895997
J Mater Sci Mater Med. 2004 Apr;15(4):493-6
pubmed: 15332623
J Appl Phys. 2015 Mar 7;117(9):094302
pubmed: 25825545
Biomaterials. 2015 Jan;39:67-74
pubmed: 25477173
J Control Release. 2016 Aug 10;235:205-221
pubmed: 27264551
Small. 2014 Oct 29;10(20):4106-12
pubmed: 24947843
J Control Release. 2018 Feb 28;272:145-158
pubmed: 28442407
Materials (Basel). 2018 Feb 23;11(2):
pubmed: 29473914
Cancer Res. 2002 Dec 1;62(23):6831-6
pubmed: 12460895
Adv Healthc Mater. 2020 May;9(9):e1901058
pubmed: 32196144
Adv Drug Deliv Rev. 2011 Jan-Feb;63(1-2):24-46
pubmed: 20685224
ACS Nano. 2016 Feb 23;10(2):2436-46
pubmed: 26766814
Sci Rep. 2017 Jul 27;7(1):6661
pubmed: 28751720
ACS Nano. 2015 Jan 27;9(1):52-61
pubmed: 25493329
J Mater Chem B. 2015 Apr 21;3(15):3011-3023
pubmed: 32262501
Pharmaceutics. 2018 May 18;10(2):
pubmed: 29783687
Pharm Res. 2010 May;27(5):796-810
pubmed: 20204471
Nanotechnol Sci Appl. 2015 Dec 11;8:67-80
pubmed: 26715842
Pharm Res. 2014 Dec;31(12):3274-88
pubmed: 24890197
J Control Release. 2015 Feb 28;200:138-57
pubmed: 25545217
Mol Clin Oncol. 2014 Nov;2(6):904-908
pubmed: 25279172
Theranostics. 2019 Feb 12;9(5):1288-1302
pubmed: 30867831
Nanomedicine (Lond). 2013 Sep;8(9):1509-28
pubmed: 23914966
Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86
pubmed: 22390560
Nanomedicine (Lond). 2018 Sep;13(17):2155-2169
pubmed: 30265184
J Control Release. 2014 Dec 10;195:37-48
pubmed: 25176578
Theranostics. 2016 Aug 07;6(11):1887-98
pubmed: 27570558
Int J Pharm. 2003 Nov 28;267(1-2):1-12
pubmed: 14602379
Cancer Chemother Pharmacol. 2016 Feb;77(2):269-80
pubmed: 26666650
Int J Hyperthermia. 2017 May;33(3):354-363
pubmed: 27690681
Adv Drug Deliv Rev. 1998 Jun 8;32(1-2):3-17
pubmed: 10837632
J Pharm Sci. 1996 Jul;85(7):741-4
pubmed: 8818999
Curr Pharm Des. 2019;25(13):1490-1504
pubmed: 31109270
Molecules. 2018 Apr 14;23(4):
pubmed: 29662019
Sci Rep. 2018 Jan 17;8(1):982
pubmed: 29343691
Int J Nanomedicine. 2012;7:2349-59
pubmed: 22661890
Colloids Surf B Biointerfaces. 2020 Apr;188:110804
pubmed: 31972443
Curr Top Med Chem. 2014 Mar;14(5):572-94
pubmed: 24444167
Int J Mol Sci. 2020 Apr 13;21(8):
pubmed: 32294917
Nanoscale Res Lett. 2014 Sep 15;9(1):497
pubmed: 25246875
Methods Mol Biol. 2017;1522:17-22
pubmed: 27837527